Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 6
2004 4
2005 9
2006 11
2007 4
2008 4
2009 2
2010 2
2011 9
2012 5
2013 10
2014 8
2015 11
2016 4
2017 3
2018 6
2019 4
2020 6
2021 4
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence.
Bruschi M, Angeletti A, Prunotto M, Meroni PL, Ghiggeri GM; Zeus consortium; Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavalli A, Scapozza L, Patel JJ, Tan JC, Lo KC, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Giannese D, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Bui F, Trezzi B, Emmi G, Cavazzana I, Binda V, Fenaroli P, Pisan I, Montecucco C, Santoro D, Scolari F, Mescia F, Volpi S, Mosca M, Tincani A, Ravelli A, Murtas C, Candiano G, Caridi G, La Porta E, Verrina E. Bruschi M, et al. Among authors: scapozza l. Autoimmun Rev. 2024 Mar 27;23(5):103535. doi: 10.1016/j.autrev.2024.103535. Online ahead of print. Autoimmun Rev. 2024. PMID: 38552995 Review.
Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model.
Masloh S, Chevrel A, Culot M, Perrocheau A, Kalia YN, Frehel S, Gaussin R, Gosselet F, Huet S, Zeisser Labouebe M, Scapozza L. Masloh S, et al. Among authors: scapozza l. Pharmaceutics. 2024 Jan 16;16(1):116. doi: 10.3390/pharmaceutics16010116. Pharmaceutics. 2024. PMID: 38258126 Free PMC article.
Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft Model.
Huet S, Zeisser Labouebe M, Castro R, Jacquot P, Pedrault J, Viollet S, Van Simaeys G, Doumont G, Larbanoix L, Zindy E, Cunha AE, Scapozza L, Cinier M. Huet S, et al. Among authors: scapozza l. Mol Cancer Ther. 2023 Nov 1;22(11):1343-1351. doi: 10.1158/1535-7163.MCT-22-0805. Mol Cancer Ther. 2023. PMID: 37578807 Free PMC article.
Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach.
Wasilewicz A, Kirchweger B, Bojkova D, Abi Saad MJ, Langeder J, Bütikofer M, Adelsberger S, Grienke U, Cinatl J Jr, Petermann O, Scapozza L, Orts J, Kirchmair J, Rabenau HF, Rollinger JM. Wasilewicz A, et al. Among authors: scapozza l. J Nat Prod. 2023 Feb 24;86(2):264-275. doi: 10.1021/acs.jnatprod.2c00843. Epub 2023 Jan 18. J Nat Prod. 2023. PMID: 36651644 Free PMC article.
128 results